Authors: Barbaro, G Zechini, F Pellicelli, AM Francavilla, R Scotto, G Bacca, D Bruno, M Babudieri, S Annese, M Matarazzo, F Di Stefano, G Barbarini, G

Citation: G. Barbaro et al., Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial, J HEPATOL, 35(3), 2001, pp. 406-411

Authors: Scotto, G Fazio, V Campanozzi, F D'Adduzio, A

Citation: G. Scotto et al., Efficacy of treatment with lamivudine in patients with chronic active e-minus variant hepatitis B virus infection: A nonrandomized, open-label study, CURR THER R, 61(6), 2000, pp. 321-330

Authors: De Sarro, G Rizzo, M Spagnolo, C Gitto, R De Sarro, A Scotto, G Zappala, M Chimirri, A

Citation: G. De Sarro et al., Anticonvulsant activity and plasma level of 2,3-benzodiazepin-4-ones (CFMs) in genetically epilepsy-prone rats, PHARM BIO B, 63(4), 1999, pp. 621-627

Authors: De Sarro, G Di Paola, ED Gareri, P Gallelli, L Scotto, G De Sarro, A

Citation: G. De Sarro et al., Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats, EUR J PHARM, 368(2-3), 1999, pp. 149-159

Authors: Barbaro, G Di Lorenzo, G Belloni, G Ferrari, L Paiano, A Del Poggio, P Bacca, D Fruttaldo, L Mongio, F Francavilla, R Scotto, G Grisorio, B Calleri, G Annese, M Barelli, A Rocchetto, P Rizzo, G Gualandi, G Poltronieri, I Barbarini, G

Citation: G. Barbaro et al., Interferon alpha-2B and ribavirin in combination for patients with chronichepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: A randomized trial, AM J MED, 107(2), 1999, pp. 112-118